Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues
Reexamination Certificate
2006-10-06
2008-11-25
Saoud, Christine J (Department: 1649)
Chemistry: natural resins or derivatives; peptides or proteins;
Proteins, i.e., more than 100 amino acid residues
C530S324000
Reexamination Certificate
active
07456255
ABSTRACT:
The invention relates generally to genes that encode proteins that inhibit axonal growth. The invention relates specifically to genes encoding NgR protein homologs in humans and mice. The invention also includes compositions and methods for modulating the expression and activity of Nogo and the NgR proteins. Specifically, the invention includes peptides, proteins and antibodies that block Nogo-mediated inhibition of axonal extension. The compositions and methods of the invention are useful in the treatment of cranial or cerebral trauma, spinal cord injury, stroke or a demyelinating disease.
REFERENCES:
patent: 5250414 (1993-10-01), Schwab et al.
patent: 5684133 (1997-11-01), Schwab et al.
patent: 5858708 (1999-01-01), Bandman et al.
patent: 6025333 (2000-02-01), Schwab et al.
patent: 6475753 (2002-11-01), Ruben et al.
patent: 6806351 (2004-10-01), Ruben et al.
patent: 7119165 (2006-10-01), Strittmatter
patent: 2002/0025554 (2002-02-01), Khodadoust
patent: 2003/0124704 (2003-07-01), Strittmattter et al.
patent: 2005/0048520 (2005-03-01), Strittmatter et al.
patent: 2005/0221420 (2005-10-01), Barske et al.
patent: 2005/0271655 (2005-12-01), Lee et al.
patent: WO 98/06841 (1998-02-01), None
patent: WO 99/46281 (1999-09-01), None
patent: WO 99/66041 (1999-12-01), None
patent: WO 00/05364 (2000-02-01), None
patent: WO 00/31235 (2000-06-01), None
patent: WO 00/32221 (2000-06-01), None
patent: WO 00/37638 (2000-06-01), None
patent: WO 00/53756 (2000-09-01), None
patent: WO 00/53758 (2000-09-01), None
patent: WO 00/58473 (2000-10-01), None
patent: WO 00/70050 (2000-11-01), None
patent: WO0070050 (2000-11-01), None
patent: WO 00/73452 (2000-12-01), None
patent: WO 01/09162 (2001-02-01), None
patent: WO 01/51520 (2001-07-01), None
patent: WO0175067 (2001-10-01), None
patent: WO 03/018631 (2003-03-01), None
patent: WO 03/035687 (2003-05-01), None
Burgess et al. J of Cell Biol. 1990. 111:2129-2138.
Bowie et al. Science, 1990, 247:1306-1310.
Pawson et al. 2003, Science 300:445-452.
Andrade, M., et al., “Protein Repeats: Structures, Functions, and Evolution,”J. Struct. Biol. 134:117-131, Academic Press (May-Jun. 2002).
Bandtlow, C., et al., “NI-35/250/Nogo-A: A Neurite Growth Inhibitor Restricting Structural Plasticity and Regeneration of Nerve Fibers in the Adult Vertebrate CNS,”Glia 29:175-181, Wiley-Liss (Jan. 2000).
Bork, P., “Powers and Pitfalls in Sequence Analysis: The 70% Hurdle,”Genome Res. 10:398-400, Cold Spring Harbor Laboratory Press (Apr. 2000).
Bork, P. and Bairoch A., “Go hunting in sequence databases but watch out for the traps,”Trends Genet. 12:425-427, Elsevier Trends Journals (1996).
Brenner, S., “Errors in genome annotation,”Trends Genet. 15: 132-133, Elsevier Trends Journals (Apr. 1999).
Chen, M., et al., “Nogo-A is a myelin-associated neurite outgrowth inhibitor and an antigen for monoclonal antibody IN-1,”Nature403:434-439, Nature Publishing Group (Jan. 2000).
Doerks, T., et al., “Protein annotation: detective work for function prediction,”Trends Genet. 14:248-250, Elsevier Trends Journals (1998).
Domeniconi, M., et al., “Myelin-Associated Glycoprotein Interacts with the Nogo66 Receptor to Inhibit Neurite Outgrowth,”Neuron 35:283-290, Cell Press (Jul. 2002).
Fournier, A., et al., “Identification of a receptor mediating Nogo-66 inhibition of axonal regeneration,”Nature 409:341-346, Nature Publishing Group (Jan. 2001).
GrandPré, T., et al., “Identification of the Nogo inhibitor of axon regeneration as a Reticulon protein,”Nature 403:439-444, Nature Publishing Group (Jan. 2000).
GrandPré, T., et al., “Nogo-66 receptor antagonist peptide promotes axonal regeneration,”Nature 417:547-551, Nature Publishing Group (May 2002).
Gustafsson, J.-A., “New insights in oetrogen receptor (ER) research—the ERβ,”Eur. J. Cancer 36:S13-S23, Elsevier Science Ltd. (Sep. 2000).
Huber, A., et al., “Nogo-A, a Potent Inhibitor of Neurite Outgrowth and Regeneration,”Biol. Chem. 381:407-419, Walter D. Gruyter (May-Jun. 2000).
Hunt, D., et al., “Nogo Receptor mRNA Expression in Intact and Regenerating CNS Neurons,”Molec. Cell. Neurosci. 20:537-552, Academic Press (Aug. 2002).
Kobe, B. and Kajava, A., “The leucine-rich repeat as a protein recognition motif,”Curr. Opin. Structural Biol. 11:725-732, Current Biology (Dec. 2001).
Li, C., et al., “The Genetic Defect in Two Well-Studied Cases of Bernard-Soulier Syndrome: A Point Mutation in the Fifth Leucine-Rich Repeat of Platelet Glycoprotein Ibα,”Blood 86:3805-3814, American Society of Hematology (1995).
Li, M., et al., “Effect of soluble Nogo reeceptor treatment on functional and histological outcome after spinal cord injury in the rat,” Biosis Database, Accession No. PREV200400194121, Abstract No. 80.22,Presented at the 33rd Annual Meeting of the Society of Neuroscience, New Orleans, LA (Nov. 8-12, 2003).
Li, W., et al., “A Neutralizing Anti-Nogo66 Receptor Monoclonal Antibody Reverses Inhibition of Neurite Outgrowth by Central Nervous System Myelin,”J. Biol. Chem.42:43780-43788, The American Society for Biochemistry and Molecular Biology, Inc. (Oct. 2004).
Li, W., et al., “Neutralization of NGR1 May Be Sufficient to Promote Rat DRG Neurite Outgrowth in the Presence of CNS Myeline,” SFN 2003 Abstract Viewer & Itinerary Planner, Program No. 678.3,Presented at the 33rd Annual Meeting of the Society of Neuroscience, New Orleans, LA (Nov. 8-12, 2003).
Merkler, D., et al., “Locomotor Recovery in Spinal Cord-Injured Rats Treated with an Antibody Neutralizing the Myelin-Associated Neurite Growth Inhibitor Nogo-A,”J. Neurosci. 21:3665-3673, Society for Neuroscience (May 2001).
Ngo, J., et al., “Computational Complexity, Protein Structure Prediction, and the Levinthal Paradox,” inThe Protein Folding Problem and Tertiary Structure Prediction, K.M. Merz and S.M. LeGrand, eds, Springer Verlag, New York, NY, pp. 433-506 (1994).
Nykjaer, A., et al., “p75NTR—live or let die,”Curr. Opin. Neurobiol. 15:49-57, Current Biology (Feb. 2005).
Oertle, T., et al., “Nogo-A Inhibits Neurite Outgrowth and Cell Spreading with Three Discrete Regions,”J. Neurosci. 23:5393-5406, Society for Neuroscience (Jul. 2003).
Oudega, M., et al., “Neutralizing Antibodies Against Neurtie Growth Inhibitor NI-35/250 Do Not Promote Regeneration of Sensory Axons in the Adult Rat Spinal Cord,”Neuroscience100:873-883, Elsevier Science (Oct. 2000).
Pignot, V., et al., “Characterization of two novel proteins, NgRH1 and NgRH2, structurally and biochemically homologous to the Nogo-66 receptor,”J. Neurochem. 85:717-728, Blackwell Science (May 2003).
Prinjha, R., et al., “Inhibitor of neurite outgrowth in humans,”Nature 403:383-384, Nature Publishing Group (Jan. 2000).
Raineteau, O., et al., “Sprouting and regeneration after pyramidotomy and blockade of the myelin-associated neurite growth inhibitors N1 35/250 in adult rats,”Eur. J. Neurosci. 11:1486-1490, Blackwell Science (Apr. 1999).
Raineteau, O., et al., “Functional switch between motor tracts in the presence of the mAb IN-1 in the adult rat,”Proc. Natl. Acad. Sci. U.S.A.98:6929-6934, National Academy of Sciences (Jun. 2001).
Skolnick, J. and Fetrow, J., “From genes to protein structure and function: novel applications of computational approaches in the genomic era,”Trends Biotechnol.18:34-39, Elsevier Science Publishers (Jan. 2000).
Smith, T. and Zhang, X., “The challenges of genome sequence annotation or The devil is in the details,”Nat. Biotechnol.15:1222-1223, Nature America Publishing (1997).
Spillman, A., et al., Identification and Characterization of a Bovine Neurite Growth Inhibitor (bNI-220),J. Biol. Chem.273:19283-19293, American Society for Biochemistry and Molecular Biology (1998).
Cate Richard L.
Sah Dinah W. Y.
Strittmatter Stephen
Biogen Idec MA Inc.
Saoud Christine J
Sterne Kessler Goldstein & Fox P.L.L.C.
Wang Chang-Yu
Yale University
LandOfFree
Nogo receptor homologs that decrease inhibition of axonal... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Nogo receptor homologs that decrease inhibition of axonal..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Nogo receptor homologs that decrease inhibition of axonal... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4030460